radium has been researched along with Cells, Neoplasm Circulating in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hinz, S | 1 |
| Arranz, JÁ; Carles, J; Castellano, D; González Del Alba, A; Jimenez, J; López, C; Manneh, R; Mellado, B; Méndez-Vidal, MJ; Morales-Barrera, R; Perez-Gracia, JL; Porras, I; Saez, MI; Sepúlveda, JM; Suárez, C | 1 |
| Anand, M; Armstrong, AJ; Davies, C; Foo, WC; George, DJ; Gerber, D; Giannakakou, P; Gregory, SG; Gupta, S; Halabi, S; Healy, P; Kemeny, G; Leith, B; Ribar, T; Rothwell, C; Somarelli, JA; Spritzer, C; Ware, K; Wood, K; Zalutsky, MR; Zhang, J | 1 |
| Tudway, RC | 1 |
1 review(s) available for radium and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
[Monitoring of treatment for metastatic castration-resistant prostate cancer].
Topics: Abiraterone Acetate; Benzamides; Biomarkers, Tumor; Combined Modality Therapy; Disease Progression; Docetaxel; Humans; Male; Neoplastic Cells, Circulating; Nitriles; Outcome and Process Assessment, Health Care; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids | 2017 |
1 trial(s) available for radium and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.
Topics: Aged; Alkaline Phosphatase; Biomarkers, Tumor; Biopsy; Bone and Bones; Bone Neoplasms; Cadherins; Core Binding Factor Alpha 1 Subunit; Disease Progression; Gene Expression; Humans; Male; Molecular Targeted Therapy; Neoplastic Cells, Circulating; Osteonectin; Osteopontin; Prostate; Prostatic Neoplasms, Castration-Resistant; Radium; Survival Analysis; Tumor Microenvironment | 2019 |
2 other study(ies) available for radium and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cell Count; Disease Progression; Follow-Up Studies; Humans; Injections, Intravenous; Male; Neoplastic Cells, Circulating; Prognosis; Progression-Free Survival; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiotherapy Dosage; Radium | 2018 |
Precision and the imponderables in cancer treatment.
Topics: Adolescent; Adult; Antibodies; Breast Neoplasms; Cobalt Isotopes; Female; Hodgkin Disease; Humans; Mitosis; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Oxygen; Palliative Care; Radioisotope Teletherapy; Radiotherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Radium | 1971 |